BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23640888)

  • 41. Extracellular Kir2.1
    Cruz FM; Macías Á; Moreno-Manuel AI; Gutiérrez LK; Vera-Pedrosa ML; Martínez-Carrascoso I; Sánchez Pérez P; Ruiz Robles JM; Bermúdez-Jiménez FJ; Díaz-Agustín A; Martínez de Benito F; Arias-Santiago S; Braza-Boils A; Martín-Martínez M; Gutierrez-Rodríguez M; Bernal JA; Zorio E; Jiménez-Jaimez J; Jalife J
    Circ Res; 2024 Apr; 134(8):e52-e71. PubMed ID: 38497220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Caveolin-3 and Caveolae regulate ventricular repolarization.
    Markandeya YS; Gregorich ZR; Feng L; Ramchandran V; O' Hara T; Vaidyanathan R; Mansfield C; Keefe AM; Beglinger CJ; Best JM; Kalscheur MM; Lea MR; Hacker TA; Gorelik J; Trayanova NA; Eckhardt LL; Makielski JC; Balijepalli RC; Kamp TJ
    J Mol Cell Cardiol; 2023 Apr; 177():38-49. PubMed ID: 36842733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct molecular interaction of caveolin-3 with KCa1.1 channel in living HEK293 cell expression system.
    Suzuki Y; Yamamura H; Ohya S; Imaizumi Y
    Biochem Biophys Res Commun; 2013 Jan; 430(3):1169-74. PubMed ID: 23237801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac potassium inward rectifier Kir2: Review of structure, regulation, pharmacology, and arrhythmogenesis.
    Reilly L; Eckhardt LL
    Heart Rhythm; 2021 Aug; 18(8):1423-1434. PubMed ID: 33857643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Valsartan Attenuates KIR2.1 by Downregulating the Th1 Immune Response in Rats Following Myocardial Infarction.
    Li X; Hu H; Wang Y; Xue M; Li X; Cheng W; Xuan Y; Yin J; Yang N; Yan S
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):252-9. PubMed ID: 26566151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Caveolin-3 negatively regulates endocytic recycling of cardiac K
    Huo JY; Feng YL; Chen YT; Yang B; Zhi YT; Wang HJ; Yang HQ
    Am J Physiol Cell Physiol; 2023 Oct; 325(4):C1106-C1118. PubMed ID: 37746698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents.
    Hattori T; Makiyama T; Akao M; Ehara E; Ohno S; Iguchi M; Nishio Y; Sasaki K; Itoh H; Yokode M; Kita T; Horie M; Kimura T
    Cardiovasc Res; 2012 Mar; 93(4):666-73. PubMed ID: 22155372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased inward rectifier potassium current I
    Rubi L; Koenig X; Kubista H; Todt H; Hilber K
    Channels (Austin); 2017 Mar; 11(2):101-108. PubMed ID: 27560040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Common Signal Patch Drives AP-1 Protein-dependent Golgi Export of Inwardly Rectifying Potassium Channels.
    Li X; Ortega B; Kim B; Welling PA
    J Biol Chem; 2016 Jul; 291(29):14963-72. PubMed ID: 27226616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of Cardiac Kir Current (IK1) by Protein Kinase C Critically Depends on PKCβ and Kir2.2.
    Scherer D; Seyler C; Xynogalos P; Scholz EP; Thomas D; Backs J; Andrassy M; Völkers M; Karle CA; Katus HA; Zitron E
    PLoS One; 2016; 11(5):e0156181. PubMed ID: 27214373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of a Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for the Study of Variant Pathogenicity: Validation of a
    Gélinas R; El Khoury N; Chaix MA; Beauchamp C; Alikashani A; Ethier N; Boucher G; Villeneuve L; Robb L; Latour F; Mondesert B; Rivard L; Goyette P; Talajic M; Fiset C; Rioux JD
    Circ Cardiovasc Genet; 2017 Oct; 10(5):. PubMed ID: 29021306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel inwardly rectifying K+ channel, Kir2.5, is upregulated under chronic cold stress in fish cardiac myocytes.
    Hassinen M; Paajanen V; Vornanen M
    J Exp Biol; 2008 Jul; 211(Pt 13):2162-71. PubMed ID: 18552306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions.
    Ponce-Balbuena D; López-Izquierdo A; Ferrer T; Rodríguez-Menchaca AA; Aréchiga-Figueroa IA; Sánchez-Chapula JA
    J Pharmacol Exp Ther; 2009 Nov; 331(2):563-73. PubMed ID: 19654266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Investigation of the Effects of the Short QT Syndrome D172N Kir2.1 Mutation on Ventricular Action Potential Profile Using Dynamic Clamp.
    Du C; Rasmusson RL; Bett GC; Franks B; Zhang H; Hancox JC
    Front Pharmacol; 2021; 12():794620. PubMed ID: 35115940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo and in vitro functional characterization of Andersen's syndrome mutations.
    Bendahhou S; Fournier E; Sternberg D; Bassez G; Furby A; Sereni C; Donaldson MR; Larroque MM; Fontaine B; Barhanin J
    J Physiol; 2005 Jun; 565(Pt 3):731-41. PubMed ID: 15831539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA Biophysically Modulates Cardiac Action Potential by Direct Binding to Ion Channel.
    Yang D; Wan X; Dennis AT; Bektik E; Wang Z; Costa MGS; Fagnen C; Vénien-Bryan C; Xu X; Gratz DH; Hund TJ; Mohler PJ; Laurita KR; Deschênes I; Fu JD
    Circulation; 2021 Apr; 143(16):1597-1613. PubMed ID: 33590773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome.
    Doi T; Makiyama T; Morimoto T; Haruna Y; Tsuji K; Ohno S; Akao M; Takahashi Y; Kimura T; Horie M
    Circ Cardiovasc Genet; 2011 Jun; 4(3):253-60. PubMed ID: 21493816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Andersen's syndrome mutants produce a knockdown of inwardly rectifying K
    Simkin D; Robin G; Giuliano S; Vukolic A; Moceri P; Guy N; Wagner KD; Lacampagne A; Allard B; Bendahhou S
    Cell Tissue Res; 2018 Feb; 371(2):309-323. PubMed ID: 29018970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low voltage activation of KCa1.1 current by Cav3-KCa1.1 complexes.
    Rehak R; Bartoletti TM; Engbers JD; Berecki G; Turner RW; Zamponi GW
    PLoS One; 2013; 8(4):e61844. PubMed ID: 23626738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The IK1/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat.
    Zhai XW; Zhang L; Guo YF; Yang Y; Wang DM; Zhang Y; Li P; Niu YF; Feng QL; Wu BW; Cao JM; Liu QH
    PLoS One; 2017; 12(5):e0177600. PubMed ID: 28542320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.